Characteristics of study participants
Subjects | Age (yrs) | Sex | FEV1pre-BD (% pred) | FEV1post-BD (% pred) | Change in FEV1 after BD (%) | PD20M (mg) | ICS dosage (μg/day) | Atopy status |
---|---|---|---|---|---|---|---|---|
Asthmatic subjects not on ICS | ||||||||
1 | 23 | M | 97 | 102 | 5.2 | 0.03 | N/A | + |
21-160 | 48 | M | 72 | 87 | 20.8 | 0.02 | N/A | + |
31-160 | 41 | M | 110 | 115 | 4.5 | 0.07 | N/A | + |
4 | 32 | M | 114 | 121 | 6.1 | 0.23 | N/A | + |
5 | 44 | M | 58 | 82 | 41.1 | 0.002 | N/A | + |
61-160 | 22 | F | 99 | 105 | 6.1 | 0.03 | N/A | + |
71-160 | 35 | F | 73 | 82 | 12.3 | 0.08 | N/A | − |
Mean | 35 | 89 | 99.1 | 13.8 | 0.0331-150 | |||
Interquartile range | 23–44 | 72–110 | 82–115 | 5.2–20.8 | 0.02–0.08 | |||
Asthmatic subjects on ICS | ||||||||
1 | 45 | M | 96 | 124 | 29.2 | 0.16 | 200 | + |
2 | 69 | M | 71 | 90 | 26.8 | 0.01 | 500 | + |
3 | 51 | F | 99 | 112 | 13.1 | 0.001 | 500 | + |
4 | 34 | M | 91 | 105 | 15.4 | 0.07 | 400 | + |
51-160 | 64 | F | 97 | 125 | 28.9 | 0.08 | 200 | − |
6 | 24 | F | 98 | 111 | 13.3 | 0.11 | 500 | − |
7 | 61 | M | 103 | 108 | 4.9 | 0.63 | 1000 | + |
8 | 50 | M | 90 | 100 | 11.1 | 0.01 | 1000 | + |
9 | 23 | F | 99 | 103 | 4 | 0.04 | 800 | + |
10 | 49 | M | 81 | 91 | 12.3 | 0.49 | 800 | + |
11 | 55 | M | 65 | 91 | 40 | 0.02 | 800 | + |
121-160 | 32 | M | 76 | 95 | 25 | 0.01 | 1000 | + |
131-160 | 48 | M | 60 | 81 | 35 | 0.01 | 1500 | − |
14 | 64 | M | 98 | 116 | 18.4 | 0.03 | 1000 | − |
151-160 | 49 | F | 96 | 111 | 15.6 | 0.03 | 1000 | − |
Mean | 48 | 88 | 104.2 | 19.5 | 0.0361-150 | 746.7 | ||
Interquartile range | 34–61 | 76–98 | 91–112 | 12.3–28.9 | 0.01–0.16 | 500–1000 | ||
Non-asthmatic controls | ||||||||
1 | 37 | M | 95 | N/D | N/D | 6.4 | N/A | + |
2 | 22 | F | 103 | N/D | N/D | Negative | N/A | + |
3 | 44 | M | 80 | 86 | N/D | Negative | N/A | + |
4 | 24 | M | 117 | N/D | N/D | Negative | N/A | + |
51-160 | 23 | M | 109 | 114 | N/D | Negative | N/A | − |
6 | 20 | M | 102 | N/D | N/D | Negative | N/A | − |
7 | 21 | F | 125 | N/D | N/D | Negative | N/A | − |
8 | 25 | M | 105 | 100 | N/D | Negative | N/A | − |
91-160 | 21 | F | 96 | 101 | N/D | Negative | N/A | − |
101-160 | 32 | M | 110 | 116 | N/D | Negative | N/A | − |
11 | 20 | M | 117 | N/D | N/D | Negative | N/A | − |
Mean | 26 | 105.4 | ||||||
Interquartile range | 21–32 | 96–117 |